We are live on ! Find out more
PCA

Private Capital Advisors Portfolio holdings

AUM $1.14B
1-Year Est. Return 48.66%
This Fund
S&P 500
This Quarter Est. Return
+12.88%
1 Year Est. Return
+48.66%
3 Year Est. Return
+137.63%
5 Year Est. Return
+227.94%
10 Year Est. Return
+772.14%
AUM
$591M
AUM Growth
+$55.8M
Cap. Flow
-$7.03M
Cap. Flow %
-1.19%
Top 10 Hldgs %
48.98%
Holding
114
New
11
Increased
11
Reduced
38
Closed
17

Top Buys

Rank Stock Value
1
ADBE icon
Adobe
ADBE
+$10.7M
2
MSFT icon
Microsoft
MSFT
+$10.3M
3
DHR icon
Danaher
DHR
+$8.64M
4
LLY icon
Eli Lilly
LLY
+$7.04M
5
AMZN icon
Amazon
AMZN
+$3.39M

Top Sells

Rank Stock Value
1
SDGR icon
Schrodinger
SDGR
+$11.3M
2
ANSS
Ansys
ANSS
+$8.32M
3
CELL
PhenomeX Inc. Common Stock
CELL
+$5.07M
4
BBWI icon
Bath & Body Works
BBWI
+$4.14M
5
CHGG icon
Chegg
CHGG
+$3.21M

Sector Composition

Rank Sector Weight
1 Healthcare 31.92%
2 Technology 21.79%
3 Industrials 12.6%
4 Communication Services 9.34%
5 Financials 8.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LSXMA
76
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$249K 0.04%
7,281
BLUE
77
DELISTED
bluebird bio
BLUE
$246K 0.04%
+594
New +$235K
SPY icon
78
State Street SPDR S&P 500 ETF Trust
SPY
$825B
$245K 0.04%
573
SRPT icon
79
Sarepta Therapeutics
SRPT
$2.2B
$241K 0.04%
+3,100
New +$235K
ATRA icon
80
Atara Biotherapeutics
ATRA
$92.3M
$233K 0.04%
+600
New +$214K
HQH
81
abrdn Healthcare Investors
HQH
$1.3B
$224K 0.04%
8,722
PG icon
82
Procter & Gamble
PG
$334B
$220K 0.04%
1,630
LADR
83
Ladder Capital
LADR
$1.25B
$209K 0.04%
18,098
FSTX
84
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$112K 0.02%
13,083
JSDA
85
DELISTED
JONES SODA CO
JSDA
$41K 0.01%
+83,000
New +$41K
AFRM icon
86
Affirm
AFRM
$26.2B
-5,000
Closed -$354K
ANSS
87
DELISTED
Ansys
ANSS
-24,497
Closed -$8.32M
BMY icon
88
Bristol-Myers Squibb
BMY
$136B
-3,516
Closed -$222K
DIS icon
89
Walt Disney
DIS
$187B
-1,128
Closed -$208K
DOCU
90
DocuSign
DOCU
$12.2B
-2,083
Closed -$422K
IBM icon
91
IBM
IBM
$222B
-2,254
Closed -$287K
MRK icon
92
Merck
MRK
$366B
-14,934
Closed -$1.1M
RCL icon
93
Royal Caribbean
RCL
$74.7B
-5,000
Closed -$428K
SDGR icon
94
Schrodinger
SDGR
$1.47B
-148,589
Closed -$11.3M
ZM icon
95
Zoom
ZM
$28.7B
-872
Closed -$280K
EMAN
96
DELISTED
eMagin Corporation
EMAN
-29,500
Closed -$110K
CELL
97
DELISTED
PhenomeX Inc. Common Stock
CELL
-100,988
Closed -$5.07M
TWTR
98
DELISTED
Twitter, Inc.
TWTR
-6,400
Closed -$407K
TRIL
99
DELISTED
Trillium Therapeutics Inc.
TRIL
-12,419
Closed -$133K

Similar funds

Private Capital Advisors's Q2 2021 Portfolio in Review

As of Q2 2021, Private Capital Advisors held 114 positions worth $591M, up 10% from $535M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Private Capital Advisors's Q2 2021 filing shows 11 new, 11 increased, 38 reduced and 17 closed positions. Its largest new stake was Adobe: 20,761 shares worth $12.2M. The largest sale was Schrodinger, an estimated $11.3M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 31% a quarter earlier, followed by Technology and Industrials.

  • Private Capital Advisors's largest Q2 2021 buy was Adobe: 20,761 shares worth $12.2M.
  • Private Capital Advisors added most to Microsoft in Q2 2021, an estimated $10.3M increase.
  • Private Capital Advisors's biggest Q2 2021 reduction was Bath & Body Works, cutting an estimated $4.14M.
  • Private Capital Advisors fully exited Schrodinger in Q2 2021, selling an estimated $11.3M.
  • Private Capital Advisors's ten largest holdings make up 49% of its $591M portfolio in Q2 2021.
  • Private Capital Advisors opened 11 new positions and closed 17 in Q2 2021.
  • Private Capital Advisors's portfolio value rose 10% quarter-over-quarter to $591M.

Based on Private Capital Advisors's 13F filing for Q2 2021, filed 6 Aug 2021.